Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 71,946

Sort by:

Amine Oxidase [Flavin Containing] A (Monoamine Oxidase Type A or MAOA or EC 1.4.3.4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Amine Oxidase [Flavin Containing] A (Monoamine Oxidase Type A or MAOA or EC 1.4.3.4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Amin...

May 2022 39 pages

Amine Oxidase [Flavin Containing] B (Monoamine Oxidase Type B or MAOB or EC 1.4.3.4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Amine Oxidase [Flavin Containing] B (Monoamine Oxidase Type B or MAOB or EC 1.4.3.4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Amin...

May 2022 52 pages

Amino Acid Metabolism Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Amino Acid Metabolism Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Amino Acid Metabolism Disorders Drugs in Development by Stages, Target, MoA, RoA...

May 2022 107 pages

Anal Fissure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Anal Fissure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Anal Fissure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 37 pages

Anaplastic Large Cell Lymphoma (ALCL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Anaplastic Large Cell Lymphoma (ALCL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Anaplastic Large Cell Lymphoma (ALCL) Drugs in Development by Stages, Targ...

May 2022 112 pages

Anaplastic Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Anaplastic Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Anaplastic Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 64 pages

Androgen Receptor (Dihydrotestosterone Receptor or Nuclear Receptor Subfamily 3 Group C Member 4 or DHTR or NR3C4 or AR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Androgen Receptor (Dihydrotestosterone Receptor or Nuclear Receptor Subfamily 3 Group C Member 4 or DHTR or NR3C4 or AR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecu...

May 2022 136 pages

Androgen-Sensitive Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Androgen-Sensitive Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Androgen-Sensitive Prostate Cancer Drugs in Development by Stages, Target, Mo...

May 2022 35 pages

Androgenic Alopecia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Androgenic Alopecia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Androgenic Alopecia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 52 pages

Anemia of Chronic Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Anemia of Chronic Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Anemia of Chronic Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 35 pages

Angelman Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Angelman Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Angelman Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 53 pages

Angioimmunoblastic T-Cell Lymphoma (AITL)-Immunoblastic Lymphadenopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Angioimmunoblastic T-Cell Lymphoma (AITL)-Immunoblastic Lymphadenopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Angioimmunoblastic T-Cell Lymphoma (AITL...

May 2022 96 pages

Angiopoietin 2 (Ang 2 or ANGPT2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Angiopoietin 2 (Ang 2 or ANGPT2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Angiopoietin 2 (Ang 2 or ANGPT2) Drugs in Development by...

May 2022 47 pages

Angiopoietin Related Protein 3 (Angiopoietin 5 or Angiopoietin Like Protein 3 or ANG 5 or ANGPTL3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Angiopoietin Related Protein 3 (Angiopoietin 5 or Angiopoietin Like Protein 3 or ANG 5 or ANGPTL3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Player...

May 2022 39 pages

Angiosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Angiosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Angiosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 64 pages

Angiotensin Converting Enzyme (Dipeptidyl Carboxypeptidase I or Kininase II or CD143 or ACE or EC 3.4.15.1 or EC 3.2.1.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Angiotensin Converting Enzyme (Dipeptidyl Carboxypeptidase I or Kininase II or CD143 or ACE or EC 3.4.15.1 or EC 3.2.1.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecu...

May 2022 45 pages

Anorexia Nervosa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Anorexia Nervosa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Anorexia Nervosa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 41 pages

Anterior Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Anterior Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Anterior Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 41 pages

Anthrax Protective Antigen (pa) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Anthrax Protective Antigen (pa) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Anthrax Protective Antigen (pa) Drugs in Development by T...

May 2022 38 pages

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Anti-Neutrophil Cytoplasmic Antibod...

May 2022 55 pages

Antiphospholipid Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Antiphospholipid Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Antiphospholipid Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 36 pages

Antithrombin III (ATIII or SERPINC1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Antithrombin III (ATIII or SERPINC1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Antithrombin III (ATIII or SERPINC1) Drugs in Develo...

May 2022 40 pages

Anxiety Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Anxiety Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Anxiety Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 243 pages

Aortic Valve Stenosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Aortic Valve Stenosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Aortic Valve Stenosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 38 pages

Apolipoprotein A (APOA or LPA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Apolipoprotein A (APOA or LPA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Apolipoprotein A (APOA or LPA) Drugs in Development by The...

May 2022 42 pages

Apolipoprotein A I (APOA1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Apolipoprotein A I (APOA1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Apolipoprotein A I (APOA1) Drugs in Development by Therapy Are...

May 2022 37 pages

Apolipoprotein C III (APOC3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Apolipoprotein C III (APOC3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Apolipoprotein C III (APOC3) Drugs in Development by Therapy...

May 2022 40 pages

Apolipoprotein E (APOE) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Apolipoprotein E (APOE) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Apolipoprotein E (APOE) Drugs in Development by Therapy Areas and...

May 2022 47 pages

Apolipoprotein L1 (Apolipoprotein L or APOL1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Apolipoprotein L1 (Apolipoprotein L or APOL1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Apolipoprotein L1 (Apolipoprotein L or APOL...

May 2022 35 pages

Apoptosis Regulator Bcl 2 (Protein Phosphatase 1 Regulatory Subunit 50 or BCL2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Apoptosis Regulator Bcl 2 (Protein Phosphatase 1 Regulatory Subunit 50 or BCL2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Apoptosis...

May 2022 42 pages

Appetite (Eating) Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Appetite (Eating) Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Appetite (Eating) Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 67 pages

Aquaporin 4 (Mercurial Insensitive Water Channel or WCH4 or AQP4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Aquaporin 4 (Mercurial Insensitive Water Channel or WCH4 or AQP4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Aquaporin 4 (Mercurial...

May 2022 36 pages

Arachidonate 15 Lipoxygenase (12-15 Lipoxygenase or Arachidonate 12 Lipoxygenase Leukocyte Type or Arachidonate Omega 6 Lipoxygenase or ALOX15 or EC 1.13.11.33 or EC 1.13.11.31) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Arachidonate 15 Lipoxygenase (12-15 Lipoxygenase or Arachidonate 12 Lipoxygenase Leukocyte Type or Arachidonate Omega 6 Lipoxygenase or ALOX15 or EC 1.13.11.33 or EC 1.13.11.31) Drugs in Development b...

May 2022 36 pages

Arachidonate 5 Lipoxygenase (5 Lipoxygenase or Leukotriene A4 Synthase or ALOX5 or EC 1.13.11.34) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Arachidonate 5 Lipoxygenase (5 Lipoxygenase or Leukotriene A4 Synthase or ALOX5 or EC 1.13.11.34) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players...

May 2022 42 pages

Arachidonate 5 Lipoxygenase Activating Protein (MK 886 Binding Protein or FLAP or ALOX5AP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Arachidonate 5 Lipoxygenase Activating Protein (MK 886 Binding Protein or FLAP or ALOX5AP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMAR...

May 2022 35 pages

Arenaviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Arenaviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Arenaviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 61 pages

Arginase 1 (Liver Type Arginase or Type I Arginase or ARG1 or EC 3.5.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Arginase 1 (Liver Type Arginase or Type I Arginase or ARG1 or EC 3.5.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Arginase 1 (Liv...

May 2022 35 pages

Aromatase (Estrogen Synthase or Cytochrome P 450AROM or Cytochrome P450 19A1 or CYP19A1 or EC 1.14.14.14) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Aromatase (Estrogen Synthase or Cytochrome P 450AROM or Cytochrome P450 19A1 or CYP19A1 or EC 1.14.14.14) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 37 pages

Aromatic L Amino Acid Decarboxylase (AADC or Dopa Decarboxylase or DDC or EC 4.1.1.28) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Aromatic L Amino Acid Decarboxylase (AADC or Dopa Decarboxylase or DDC or EC 4.1.1.28) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Ar...

May 2022 51 pages

Arteriosclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Arteriosclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Arteriosclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 138 pages

Articular Cartilage Defect Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Articular Cartilage Defect Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Articular Cartilage Defect Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 36 pages

Arylsulfatase A (Cerebroside Sulfatase or ASA or ARSA or EC 3.1.6.8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Arylsulfatase A (Cerebroside Sulfatase or ASA or ARSA or EC 3.1.6.8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Arylsulfatase A (Cer...

May 2022 39 pages

Ascites Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Ascites Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ascites Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an over...

May 2022 38 pages

Aspartoacylase (Aminoacylase 2 or ACY2 or ASPA or EC 3.5.1.15) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Aspartoacylase (Aminoacylase 2 or ACY2 or ASPA or EC 3.5.1.15) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Aspartoacylase (Aminoacyla...

May 2022 40 pages

Ataxin 3 (Machado Joseph Disease Protein 1 or Spinocerebellar Ataxia Type 3 Protein or SCA3 or ATXN3 or EC 3.4.19.12) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Ataxin 3 (Machado Joseph Disease Protein 1 or Spinocerebellar Ataxia Type 3 Protein or SCA3 or ATXN3 or EC 3.4.19.12) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule...

May 2022 38 pages

Atopic Keratoconjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Atopic Keratoconjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Atopic Keratoconjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 35 pages

ATP Dependent Clp Protease Proteolytic Subunit Mitochondrial (Endopeptidase Clp or CLPP or EC 3.4.21.92) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

ATP Dependent Clp Protease Proteolytic Subunit Mitochondrial (Endopeptidase Clp or CLPP or EC 3.4.21.92) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 38 pages

Atrophic Vaginitis (Vaginal Atrophy-Vulvovaginal Atrophy-Urogenital Atrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Atrophic Vaginitis (Vaginal Atrophy-Vulvovaginal Atrophy-Urogenital Atrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Atrophic Vaginitis (Vaginal Atrophy...

May 2022 38 pages

Auto Inflammatory Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Auto Inflammatory Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Auto Inflammatory Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 39 pages

Autoimmune Hepatitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Autoimmune Hepatitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Autoimmune Hepatitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 44 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

33% OFF on “TCR-Based Antibody a...

Discount Offer from GMD Research

280

Special Offer from MP Advisors

Special Offer on Therapy Class R...